What type of study are you interested in?

Psoriasis Study Opportunities

Clinical research study to evaluate a new investigational drug in adults with moderate to severe plaque psoriasis.

Study 1

Inclusion Criteria:

• In general good health 18 years of age or older
• Clinical diagnosis of moderate to severe plaque psoriasis for 6 months or longer
• 10% or more body surface area (BSA) affected with plaque psoriasis

Exclusion Criteria:

• Non-plaque psoriasis
• Pregnant, planning a pregnancy or nursing
• Positive TB skin test within 3 months of screening
• Acute or chronic lung disease
• Body Mass Index (BMI) greater than 40
• History of any cancer within 5 years, except for successfully treated basal cell or squamous cell cancer of the skin and in-situ cancer of the cervix
• History of positive test for hepatitis B surface or hepatitis C antibody or history of a positive test for human immunodeficiency virus (HIV) infection
• Uncontrolled illness, including, but not limited to ongoing or active infection, any significant heart disease as determined by the study doctor, seizure disorder, or psychiatric illness/social situations that would limit compliance with study requirements
• Participation in another clinical research study

Study 2

Clinical research study to evaluate a new investigational topical drug in people ages 12 and older with moderate plaque psoriasis on their body and scalp

Inclusion Criteria:

• In general good health 12 years of age or older
• Clinical diagnosis of moderate plaque psoriasis on scalp and body
• 10% or more scalp surface area affected with plaque psoriasis

Exclusion Criteria:

• Non-plaque psoriasis
• Participation in previous calcipotriene foam clinical trial
• Pregnant, planning a pregnancy or nursing
• Known allergy or other adverse reaction to calcipotriene or other vitamin D analogs
• Current drug or alcohol abuse
• History of immunocompromising disease
• Participation in another clinical research study

Study 3

Clinical research study to evaluate a new investigational topical drug in people ages 18 and older with moderate to severe plaque psoriasis on their body.

Inclusion Criteria:

• In general good health 18 years of age or older
• Clinical diagnosis of moderate to severe plaque psoriasis on body
• 20% or more body surface area affected with plaque psoriasis

Exclusion Criteria:

• Non-plaque psoriasis
• Pregnant, planning a pregnancy or nursing
• Participation in another clinical research study
• Subject has irregular sleep schedule or works night shift

Call our recruitment department for more details. Your confidentiality is always maintained. 858-279-SKIN or 858-571-6800 x130

 

Onychomycosis (Toenail Fungus)

This study will determine the efficacy of an investigational therapy using a biodegradable, sustained-release formulation around the nailbed.

Inclusion Criteria
-	18-75 years of age, in good health
-	20%-75% involvement of at least one big toe
-	Presence of at least 2mm of clear (unaffected) nail on the target nail
-	Willing to avoid the use of nail polish, cosmetic toenail products, and pedicures during the study period
-	Satisfy other study entry requirements (as provided by study site staff)
Exclusion Criteria
-	Pregnant, nursing or planning a pregnancy
-	Failure to respond to previous treatment with oral terbinafine
-	Have fingernails affected by nail fungus
-	Chronic foot pain, skin disease, and/or injury in treated foot
-	Systemic anti-fungal medications within three months of study participation
-	Topical anti-fungal and/or topical cortico-steroid products within 14 days of study participation
-	Significant disease or health conditions which could interfere with or confound the results of the study
-	Currently participating in another clinical trial with an investigational drug or device

Call our recruitment department for more details. No health insurance is required.
619-512-DERM (3376) or 858-571-6800 x130.

 

Do You Have Hand Eczema?

Are you seeking relief from red, dry, cracked and inflamed skin on your hands? Have you been diagnosed with chronic hand eczema, also known as hand dermatitis? If you are suffering from this distressing disease, we may have a clinical research trial for you.

Therapeutics Clinical Research is evaluating the efficacy of Alitretinoin in the treatment of severe, chronic hand eczema. If you are 18-75 years of age and have had hand eczema for at least six months, we invite you to participate. Qualified participants will receive all study-related examinations and study medication at no cost plus compensation for time and travel. No health insurance is required and you confidentiality is always maintained.

Call us at (858) 279-7546 to schedule a free evaluation.